Amendment_4_BAA-NIAID-NIHAI201700104.pdf
PDF 19 KB Posted
- Solicitation number
- BAA-NIAID-NIHAI201700104
About this file
This document is an amendment to a Broad Agency Announcement soliciting proposals for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center program. The National Institute of Allergy and Infectious Diseases seeks to establish an integrated multi-disciplinary team to conduct iterative immunological analyses of tissue-specific and systemic responses in small animals, non-human primates, and humans to identify key immune responses needed for protection against Mycobacterium tuberculosis. Contractors will be responsible for leadership structure, data and resource management systems, and in-depth immunological analyses examining at least two of three stages of M. tuberculosis infection and progression to active tuberculosis disease using small animal models, non-human primates, and human studies. One to three cost reimbursement, completion type contracts will be awarded with anticipated performance beginning August 1, 2019. The National Institute of Allergy and Infectious Diseases anticipates total funding of up to $19.5 million for all awards.
Amendment 4 BAA-NIAID-NIHAI201700104
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Amendment No. 4 to BAA-NIAID-NIHAI201700104 “Immune Mechanisms of Protection against Mycobacterium tuberculosis Center (IMPAc-TB)”
Amendment to Solicitation No.: BAA-NIAID-NIHAI2001700104
Amendment No.: 4
Issue Date: August 8, 2018
Effective Date:
Proposal Due Date:
August 8, 2018
August 15, 2018 at 3:00 p.m. (ET)
Issued By: Liem T. Nguyen Contracting Officer
NIH/NIAID
Office of Acquisitions 5601 Fishers Lane, MSC 9821 Rockville, MD 20892-9821
Point of Contact: Albert Nguyen, Contract Specialist nguyenal@niaid.nih.gov
Name and Address of Offeror: To All Potential Offerors
The above numbered solicitation is amended as set forth below. The hour and date specified for receipt of proposals remain unchanged. Offerors must acknowledge receipt of this amendment. Failure to provide your acknowledgement of this amendment may result in the rejection of your offer.
SECTION 1 – QUESTIONS AND RESPONSES
This section of the amendment provides questions submitted by potential applicants/offerors and the responses provided by NIAID. The responses are offered for information only and do not modify or become part of this solicitation. This Amendment will be updated as needed to add further questions and their related responses. All potential offerors are advised to refer back to the solicitation and its amendments for additional Questions & Answers.
Question 1: The PHS Human Subjects and Clinical Trials Information form will be submitted via the electronic Contract Proposal Submission (eCPS) website, does that mean the form is not included in the technical proposal 150 page limit?
Response 1: There is a separate upload link in the eCPS website for the PHS Human Subjects Form in addition to the business and technical proposal. The PHS Human Subjects and Clinical Trials Information Form is not included in the technical proposal 150 Page Limit.
mailto:nguyenal@niaid.nih.gov
| Amendment No. 4 to BAA-NIAID-NIHAI201700104 |
| “Immune Mechanisms of Protection against Mycobacterium tuberculosis Center (IMPAc-TB)” |
File details come from the government source that posted it. Updated .